Recce Pharmaceuticals' Anti-Infective Drug Candidate Showed Activity Against 'Superbug' in Skin Cell Study
Recce Pharmaceuticals' Anti-Infective Drug Candidate Showed Activity Against 'Superbug' in Skin Cell Study
Recce藥品公司的抗感染藥物候選品在皮膚細胞研究中展現出對"超級細菌"的活性。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊